ReNeuron Group plc
RENE.L · LSE
3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | |
|---|---|---|---|---|
| Market Cap | £52 | £174 | £466 | £315 |
| - Cash | £6,153 | £9,548 | £14,703 | £12,625 |
| + Debt | £421 | £562 | £719 | £873 |
| Enterprise Value | -£5,680 | -£8,812 | -£13,518 | -£11,437 |
| Revenue | £530 | £403 | £257 | £6,065 |
| % Growth | 31.5% | 56.8% | -95.8% | – |
| Gross Profit | £263 | £79 | -£9,246 | -£10,270 |
| % Margin | 49.6% | 19.6% | -3,597.7% | -169.3% |
| EBITDA | -£6,370 | -£10,709 | -£12,998 | -£13,404 |
| % Margin | -1,201.9% | -2,657.3% | -5,057.6% | -221% |
| Net Income | -£5,408 | -£9,689 | -£11,347 | -£11,412 |
| % Margin | -1,020.4% | -2,404.2% | -4,415.2% | -188.2% |
| EPS Diluted | -0.095 | -0.17 | -0.29 | -0.35 |
| % Growth | 44.3% | 41.4% | 17.1% | – |
| Operating Cash Flow | -£7,484 | -£7,411 | -£6,052 | -£14,304 |
| Capital Expenditures | -£220 | -£302 | -£25 | -£119 |
| Free Cash Flow | -£7,704 | -£7,713 | -£6,077 | -£14,423 |